UiPath (NYSE:PATH) Stock Price Up 0.2%

UiPath Inc. (NYSE:PATH)’s share price traded up 0.2% during mid-day trading on Friday . The stock traded as high as $19.11 and last traded at $19.07. 1,579,310 shares traded hands during mid-day trading, a decline of 80% from the average session volume of 7,968,873 shares. The stock had previously closed at $19.04.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Bank of America raised their price target on UiPath from $26.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, March 14th. Wells Fargo & Company increased their target price on UiPath from $24.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, March 14th. Scotiabank increased their target price on UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a research note on Thursday, March 14th. KeyCorp began coverage on UiPath in a research note on Monday, April 8th. They issued an “overweight” rating and a $27.00 target price on the stock. Finally, Evercore ISI increased their target price on UiPath from $24.00 to $27.00 and gave the company an “in-line” rating in a research note on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, UiPath currently has a consensus rating of “Moderate Buy” and an average price target of $27.41.

UiPath Price Performance

The company has a market cap of $10.80 billion, a price-to-earnings ratio of -111.64 and a beta of 1.01. The stock has a 50-day moving average price of $20.63 and a 200 day moving average price of $22.10.

UiPath (NYSE:PATH) last posted its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. The business had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. Sell-side analysts expect that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Ashim Gupta sold 40,000 shares of the stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $21.66, for a total transaction of $866,400.00. Following the completion of the transaction, the chief financial officer now directly owns 660,762 shares in the company, valued at $14,312,104.92. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Over the last three months, insiders sold 96,000 shares of company stock worth $2,023,440. 22.37% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Mark Sheptoff Financial Planning LLC bought a new position in UiPath in the fourth quarter valued at approximately $25,000. HighMark Wealth Management LLC bought a new position in shares of UiPath during the 4th quarter worth approximately $27,000. ORG Partners LLC boosted its stake in shares of UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after acquiring an additional 1,112 shares during the period. Cypress Capital Management LLC WY bought a new position in shares of UiPath during the 4th quarter worth approximately $29,000. Finally, Fifth Third Bancorp boosted its stake in shares of UiPath by 2,005.3% during the 3rd quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock worth $34,000 after acquiring an additional 1,905 shares during the period. 62.50% of the stock is currently owned by institutional investors.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.